Mirum Pharmaceuticals Q2 Product Sales USD 176.243 Million
MIRM•Quarterly product sales and profitability
Aug. 5 (Reuters) - Mirum Pharmaceuticals Q2 product sales were USD 176.243 million.
- Q2 operating expenses: USD 218.78 million
- Q2 operating income: USD -42.537 million
- Q2 net income: USD -67.227 million




